Patents Assigned to Indapta Therapeutics, Inc.
  • Engineered natural killer (NK) cells and compositions and methods thereof
    Patent number: 11920156
    Abstract: The present invention provides engineered Natural Killer (NK) cells and methods of producing engineered NK cells. The engineered NK cells and compositions containing the engineered NK cells are useful for treating diseases such as cancer.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: March 5, 2024
    Assignee: Indapta Therapeutics, Inc.
    Inventor: Guy Dipierro
  • NATURAL KILLER (NK) CELL COMPOSITIONS AND METHODS FOR GENERATING SAME
    Publication number: 20230190801
    Abstract: Provided herein are methods for ex vivo expansion of a specialized subset of natural killer (NK) cells, and compositions containing such NK cells. Also provided are methods for identifying or detecting a specialized subset of NK cells. Also provided are methods for treating diseases and conditions such as cancer using provided compositions, including in combination with an antibody capable of binding to disease-associated tissues or cells, such as tumor cells or infected cells.
    Type: Application
    Filed: April 21, 2021
    Publication date: June 22, 2023
    Applicant: Indapta Therapeutics, Inc.
    Inventors: Austin BIGLEY, Guy DIPIERRO
  • METHODS FOR EXPANSION OF NATURAL KILLER (NK) CELL SUBSET AND RELATED COMPOSITIONS AND METHODS
    Publication number: 20220008466
    Abstract: Provided herein are methods for ex vivo expansion of a specialized subset of natural killer (NK) cells, and compositions containing such NK cells. Also provided are methods for identifying or detecting a specialized subset of NK cells. Also provided are methods for treating diseases and conditions such as cancer using provided compositions, including in combination with an antibody capable of binding to disease-associated tissues or cells, such as tumor cells or infected cells.
    Type: Application
    Filed: November 21, 2019
    Publication date: January 13, 2022
    Applicant: Indapta Therapeutics, Inc
    Inventors: Austin BIGLEY, Ronald MARTELL, Guy DIPIERRO
  • SUBSETS OF HUMAN NATURAL KILLER CELLS WITH ENHANCED ANTIBODY-DIRECTED IMMUNE RESPONSES
    Publication number: 20210187025
    Abstract: Provided herein are compositions containing specialized subsets of natural killer (NK) cells with enhanced antibody-directed immune responses. The compositions are useful for treating diseases and conditions such as cancer, including in combination with an antibody capable of binding to disease-associated tissues or cells, such as tumor cells or infected cells.
    Type: Application
    Filed: May 14, 2019
    Publication date: June 24, 2021
    Applicant: Indapta Therapeutics, Inc.
    Inventors: Guy DIPIERRO, Gary DOS SANTOS
  • ENGINEERED NATURAL KILLER (NK) CELLS AND COMPOSITIONS AND METHODS THEREOF
    Publication number: 20190376036
    Abstract: The present invention provides engineered Natural Killer (NK) cells and methods of producing engineered NK cells. The engineered NK cells and compositions containing the engineered NK cells are useful for treating diseases such as cancer.
    Type: Application
    Filed: February 8, 2018
    Publication date: December 12, 2019
    Applicant: Indapta Therapeutics, Inc.
    Inventor: Guy DIPIERRO